Form S-3 Karyopharm Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Karyopharm Therapeutics (KPTI) files for 8.84M share offering by selling stockholders
May 4, 2026 4:41 PM EDTKaryopharm Therapeutics (NASDAQ: KPTI) has filed for up to 8,843,036 share offering by selling stockholders.
... MoreKaryopharm Therapeutics (KPTI) files $400M mixed shelf
May 4, 2026 4:38 PM EDTKaryopharm Therapeutics (NASDAQ: KPTI) has filed $400,000,000 mixed shelf of:
Debt Securities
Common Stock
Preferred Stock
Units
Warrants
... More